Participant flow

Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma · Source last updated 2011-11-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Curcumin starting dose 2 grams orally in two divided doses (a.m., p.m.)

   id

   FG000

   title

   Curcumin

2. description

   Curcumin starting dose 2 grams orally in 2 divided doses (a.m., p.m.) and Bioperine 5 mg orally twice daily

   id

   FG001

   title

   Curcumin + Bioperine

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         2

      type

      Disease progression

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Non-compliant

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         16

      2. group Id

         FG001

         num Subjects

         17

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         15

      2. group Id

         FG001

         num Subjects

         15

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         2

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

Of 42 patients enrolled, 9 were excluded from the trial prior to group assignment because of screen failure.

recruitment Details

Recruitment period: 11/2004 to 1/2008. All participants were recruited at UT MD Anderson Cancer Center.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice